Literature DB >> 12133954

A role for NF-kappa B activation in perforin expression of NK cells upon IL-2 receptor signaling.

Jun Zhou1, Jin Zhang, Mathias G Lichtenheld, Gary G Meadows.   

Abstract

Optimal NK cell development and activation as well as cytolytic activity involves IL-2R beta signals that also up-regulate expression of the pore-forming effector molecule perforin. Although the Jak/Stat pathway and specifically Stat5 transcription factors are required to promote many of the respective downstream events, the role of additional signaling pathways and transcription factors remains to be clarified. This report investigates the role of NF-kappa B activation for perforin expression by NK cells. It is demonstrated that IL-2-induced up-regulation of perforin in primary NK cells and in a model cell line is blocked by two pharmacological agents known to inhibit NF-kappa B activation. Direct evidence for the activation of the NF-kappa B pathway by IL-2R signals in NK cells involves activation of the IKK alpha kinase, inhibitory protein kappa B alpha degradation, nuclear translocation of p50/p65 complexes, and ultimately, transcriptional activation of the perforin gene via an NF-kappa B binding element in its upstream enhancer. Taken together, these observations strongly suggest that IL-2R signals can activate a pathway leading to NF-kappa B activation in NK cells and that this pathway is involved in the control of perforin expression.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12133954     DOI: 10.4049/jimmunol.169.3.1319

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  27 in total

Review 1.  The transcriptional control of the perforin locus.

Authors:  Matthew E Pipkin; Anjana Rao; Mathias G Lichtenheld
Journal:  Immunol Rev       Date:  2010-05       Impact factor: 12.988

2.  Human T cell leukaemia virus type 2 tax protein mediates CC-chemokine expression in peripheral blood mononuclear cells via the nuclear factor kappa B canonical pathway.

Authors:  C S Barrios; L Castillo; H Zhi; C-Z Giam; M A Beilke
Journal:  Clin Exp Immunol       Date:  2014-01       Impact factor: 4.330

Review 3.  Exploiting our knowledge of NF-kappaB signaling for the treatment of mammary cancer.

Authors:  Michael C Haffner; Chiara Berlato; Wolfgang Doppler
Journal:  J Mammary Gland Biol Neoplasia       Date:  2006-01       Impact factor: 2.673

Review 4.  Formation and function of the lytic NK-cell immunological synapse.

Authors:  Jordan S Orange
Journal:  Nat Rev Immunol       Date:  2008-09       Impact factor: 53.106

5.  NKG2D receptor-mediated NK cell function is regulated by inhibitory Ly49 receptors.

Authors:  Jeyarani Regunathan; Yuhong Chen; Demin Wang; Subramaniam Malarkannan
Journal:  Blood       Date:  2004-08-24       Impact factor: 22.113

Review 6.  NF-κB, inflammation, immunity and cancer: coming of age.

Authors:  Koji Taniguchi; Michael Karin
Journal:  Nat Rev Immunol       Date:  2018-01-22       Impact factor: 53.106

7.  NKp30 ligation induces rapid activation of the canonical NF-kappaB pathway in NK cells.

Authors:  Rahul Pandey; Christine M DeStephan; Lisa A Madge; Michael J May; Jordan S Orange
Journal:  J Immunol       Date:  2007-12-01       Impact factor: 5.422

8.  Opposing roles of NF-kappaB family members in the regulation of NK cell proliferation and production of IFN-gamma.

Authors:  Cristina M Tato; Nicola Mason; David Artis; Sagi Shapira; Jorge C Caamano; Jay H Bream; Hsiou-Chi Liou; Christopher A Hunter
Journal:  Int Immunol       Date:  2006-02-15       Impact factor: 4.823

9.  Evaluation of the Functional Capacity of NK Cells of Melanoma Patients in an In Vitro Model of NK Cell Contact with K562 and FemX Tumor Cell Lines.

Authors:  Gordana Konjevic; Ana Vuletic; Katarina Mirjacic Martinovic; Ana Krivokuca; Radmila Jankovic; Nada Babovic
Journal:  J Membr Biol       Date:  2017-09-08       Impact factor: 1.843

10.  Differential expression of proteins in naïve and IL-2 stimulated primary human NK cells identified by global proteomic analysis.

Authors:  Weifeng Cao; Arvinder Kapur; Di Ma; Mildred Felder; Cameron O Scarlett; Manish S Patankar; Lingjun Li
Journal:  J Proteomics       Date:  2013-06-25       Impact factor: 4.044

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.